Read Simon bought DNTH
August 19, 2026 · Form 4 insider transaction
Read Simon bought 2,778 shares of Dianthus Therapeutics, Inc. at $18.36 per share, a transaction worth $51.0K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
2,778
Price
$18.36
Total value
$51.0K
InsiderRead Simon
RoleDirector
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateAugust 19, 2026
Filing dateAugust 19, 2026
Shares owned after2,778
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on May 8, 2026.